AzTrials
AzTrials

Multiple SclerosisNCT04881422

Sport, Rehabilitation and Nutrition in Multiple Sclerosis: The LINUS Project

A study testing B-HIPE (Brief High Impact Preparatory Experience) in people with Multiple Sclerosis, run by Fondazione Don Carlo Gnocchi ETS at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Only a limited percentage of persons with MS (pwMS) participate to multidisciplinary rehabilitation because of poor support, knowledge and motivation. The investigators reasoned that pwMS should be more effectively prepared to increase their adherence. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Multiple Sclerosis
What is being tested?
B-HIPE (Brief High Impact Preparatory Experience)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteItaly
Study dates
15 Jul 2018to 30 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • aged 18 to 70 years
  • EDSS ranging from 1 to 7.5.
  • pwMS with who are on a western diet
  • stabilized medical therapy and clinical conditions
  • pwMS with a motor control of upper limbs sufficient to maneuver a tiller

Who cannot join

  • Heavy smoking, alcohol and drugs abuse
  • severe cognitive impairment
  • dysphagia and/or comorbidities requiring protected environments and specific medical assistance
  • blindness and severe visual disturbances (included severe nystagmus)

Trial locations and contacts

1 site in 1 country.

Laura LM Mendozzi, MD contact

02 40308571 ext. +39

lmendozzi@dongnocchi.it

Italy1 site, 1 recruiting
  • IRCCS Fondazione Don Carlo Gnocchi

    Milan

    Laura Mendozzi, MD, lmendozzi@dongnocchi.it

    Recruiting

Other trials in Italy

About this study

Official title: Sport, Rehabilitation and Nutrition in Multiple Sclerosis: An Innovative Multidisciplinary High Impact Intervention for the Lifestyle Change

Only a limited percentage of persons with MS (pwMS) participate to multidisciplinary rehabilitation because of poor support, knowledge and motivation. The investigators reasoned that pwMS should be more effectively prepared to increase their adherence. This study propose the implementation of an innovative collaborative approach, called "brief high-impact preparatory experience" (b-HIPE), inspired by an overarching model based on the interplay between competence, motivation and opportunity to increase in a short time awareness and motivation of pwMS.

The aim of the study is the evaluation of its feasibility. For this pilot study the investigator chose a single-group design with repeated measurements at baseline and post intervention.

Being tested
B-HIPE (Brief High Impact Preparatory Experience)
Keywords
lifestyle, multiple sclerosis, nutrition, rehabilitation, motivation, adherence
Medical subject headings
Multiple Sclerosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • B-HIPE (Brief High Impact Preparatory Experience)Behavioural

    The intervention consists in a one-week intensive rehabilitation in which participants underwent to a multidimensional rehabilitation composed by physical rehabilitation, mental wellbeing, a proper diet and engaging physical activity (a sail course). Digital motivating reinforcements are proposed to the participants with the aim to maintain the correct lifestyle learned in the B-HIPE program.

Study groups in NCT04881422
Study groupRoleWhat they receive
Experimental groupExperimentalA group of pwMS participate in a multidimensional integrate high-motivating rehabilitation program for the change of lifestyle and bad habits.
Receives: Behavioral: B-HIPE (Brief High Impact Preparatory Experience)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. FS-36 Health Related Quality of Life (HRQoL)

    Questionnaire to Measure Health-Related Quality of Life

    Measured: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

  2. The Fatigue Severity Scale (FSS)

    Questionnaire to Measure the fatigue

    Measured: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

  3. Food frequency questionnaire (FFQ)

    Questionnaire to evaluate usual frequency of foods and beverages

    Measured: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

Secondary outcomes (5)
  1. MSIS29- Multiple Sclerosis Impact Scale

    A scale for the evaluation of the impact of MS on day-to-day life

    Measured: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

  2. MOS Sleep Scale (MOSS)

    A scale for the evaluation of the quality and the quantity of sleep

    Measured: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

  3. Restless Legs Scale (RLS)

    A scale for the evaluation of the restless legs syndrome

    Measured: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

  4. Six minute walking test (6MWT)

    An exercise test used to assess aerobic capacity and endurance

    Measured: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

  5. Hospital Anxiety and Depression Scale (HADS)

    A self-assessment scale for detecting states of depression and anxiety

    Measured: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 May 2021
  2. Study start15 Jul 2018
  3. Primary completion31 Dec 2021 (estimated)
  4. Study completion30 Jun 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04881422
Sponsor's protocol ID
07_23/05/2018
Status last verified
Apr 2021
First submitted
28 Apr 2021
Last updated
11 May 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing B-HIPE (Brief High Impact Preparatory Experience) in people with Multiple Sclerosis, run by Fondazione Don Carlo Gnocchi ETS at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Laura LM Mendozzi, MD (02 40308571 ext. +39, lmendozzi@dongnocchi.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

FS-36 Health Related Quality of Life (HRQoL) (time frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in